Related Experiment Video
Updated: May 27, 2026
07:35
Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
Published on: January 26, 2024
Hypoglycemia and adverse outcomes: marker or mediator?
Kasia J Lipska1, Mikhail Kosiborod
1Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, CT, USA.
Reviews in Cardiovascular Medicine
|November 15, 2011
Summary
Hypoglycemia, or low blood sugar, is linked to higher mortality and adverse events in patients with diabetes and acute myocardial infarction. It appears to be a marker of severe illness rather than a direct cause.
Area of Science:
- Endocrinology
- Cardiology
- Critical Care Medicine
Background:
- Hypoglycemia is frequently observed in critically ill patients.
- Its role as a mediator versus a marker of adverse outcomes remains debated.
- Previous studies indicate an association between hypoglycemia and increased mortality.
Purpose of the Study:
- To investigate the association between hypoglycemia and mortality in patients hospitalized with acute myocardial infarction.
- To examine the relationship between hypoglycemia and adverse events in patients with diabetes.
Main Methods:
- Analysis of observational data for spontaneous hypoglycemia in acute myocardial infarction patients.
- Review of data from the ADVANCE trial examining intensive glucose lowering in patients with diabetes.
Main Results:
- Spontaneous hypoglycemia, not iatrogenic, correlated with increased mortality in acute myocardial infarction patients.
- In the ADVANCE trial, intensive glucose lowering increased hypoglycemia risk.
- Hypoglycemia was linked to macrovascular, microvascular, and noncardiac adverse events, including death.
Conclusions:
- Hypoglycemia is likely a marker of severe illness and comorbidity burden, not a direct cause of death or cardiovascular events.
- Despite this, efforts to prevent hypoglycemia are crucial.
- Further research is needed to clarify the complex relationship between glucose control and patient outcomes.
Related Concept Videos
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...